Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RXFP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BOLA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | APOBEC3B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AC243756.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SRP19 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HMGA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GPRC5D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GAREM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DCUN1D2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RNF44 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |